Search Results
Jan 13, 2026, 00:32 ET Alamar Biosciences annonce le lancement du test NULISAqpcr™ AD 5-plex et fait avancer la détection des biomarqueurs sanguins dans la recherche sur la maladie d'Alzheimer
la protéomique de précision pour permettre la détection précoce des maladies. S'appuyant sur sa technologie propriétaire NULISA™ et le système ARGO™ HT, la plateforme d'Alamar est conçue pour offrir une sensibilité ultra-élevée et résoudre les principales limites des technologies existantes afin d'offrir
More news about: Alamar Biosciences, Inc.
Jan 12, 2026, 23:18 ET Alamar Biosciences Umumkan Penutupan Pendanaan Obligasi Konversi yang Mengalami Kelebihan Permintaan dan Perluasan Tim Kepemimpinan
bidang ilmu hayati yang berkomitmen untuk mendukung proteomik presisi guna mendeteksi penyakit lebih dini. Dengan memanfaatkan teknologi NULISA™ dan ARGO™ HT System eksklusifnya, platform Alamar dirancang untuk menyediakan sensitivitas amat sangat tinggi dan mengatasi berbagai keterbatasan utama yang dialami
More news about: Alamar Biosciences, Inc.
Jan 12, 2026, 17:27 ET Alamar Biosciences Announces Launch of NULISAqpcr™ AD 5-plex Assay, Advancing Blood Based Biomarker Detection in Alzheimer's Disease Research
company dedicated to powering precision proteomics to enable the earliest detection of disease. Leveraging its proprietary NULISA™ technology and the ARGO™ HT System, Alamar's platform is designed to deliver ultra-high sensitivity and addresses key limitations of existing technologies to deliver precision proteomics.
More news about: Alamar Biosciences, Inc.
Jan 12, 2026, 17:27 ET Alamar Biosciences Announces Launch of NULISAqpcr™ AD 5-plex Assay, Advancing Blood Based Biomarker Detection in Alzheimer's Disease Research
company dedicated to powering precision proteomics to enable the earliest detection of disease. Leveraging its proprietary NULISA™ technology and the ARGO™ HT System, Alamar's platform is designed to deliver ultra-high sensitivity and addresses key limitations of existing technologies to deliver precision proteomics.
More news about: Alamar Biosciences, Inc.
Jan 12, 2026, 11:44 ET Alamar Biosciences uzatvára nadupísané financovanie formou konvertibilných dlhopisov a rozširuje vedenie spoločnosti
oblasti biologických vied zameraná na podporu presnej proteomiku, s cieľom odhaľovať choroby čo najskôr. Využíva vlastnú technológiu NULISA™ a systém ARGO™ HT System; platforma spoločnosti je navrhnutá tak, aby prinášala mimoriadne vysokú citlivosť a riešila kľúčové obmedzenia existujúcich technológií v oblasti
More news about: Alamar Biosciences, Inc.
Jan 12, 2026, 11:35 ET Alamar Biosciences 宣佈完成超額認購可換股票據融資並擴充領導團隊
而言是振奮人心的時刻，我們期待在他們的領導下，推動公司再創創新與增長的高峰。」關於 Alamar Biosciences, Inc.Alamar Biosciences 是一家私人持股的生命科學公司，致力推動精準蛋白質組學發展，以實現疾病的最早期檢測。憑藉其專有的 NULISA™ 技術及 ARGO™ HT 系統，Alamar 的平台旨在提供超高靈敏度檢測，解決現有技術在精準蛋白質組學應用上的關鍵局限。如欲了解更多資料，請瀏覽
More news about: Alamar Biosciences, Inc.
Jan 12, 2026, 10:17 ET Alamar Biosciences thông báo hoàn tất vòng gọi vốn trái phiếu chuyển đổi vượt mức đăng ký và mở rộng đội ngũ lãnh đạo.
tư nhân hoạt động trong lĩnh vực khoa học sự sống chuyên cung cấp công nghệ proteomics chính xác để phát hiện bệnh sớm nhất. Tận dụng hệ thống ARGO™ HT và công nghệ NULISA™ độc quyền, công nghệ của Alamar được thiết kế để mang lại độ nhạy siêu cao và khắc phục những hạn chế mấu chốt của các công nghệ
More news about: Alamar Biosciences, Inc.
Jan 12, 2026, 10:14 ET Компания Alamar Biosciences объявляет о закрытии финансирования за счет конвертируемых облигаций с превышением лимита подписки и о расширении руководящей команды
обеспечении возможности использовать прецизионную протеомику для ранней диагностики заболеваний. Используя патентованную технологию NULISA™ и систему ARGO™ HT, платформа компании Alamar должна обеспечить сверхвысокую чувствительность и устранить ключевые ограничения существующих технологий для обеспечения прецизионной
More news about: Alamar Biosciences, Inc.
Jan 12, 2026, 08:08 ET Alamar Biosciences anuncia el cierre de la financiación de bonos convertibles
dedicada a impulsar la proteómica de precisión para la detección temprana de enfermedades. Gracias a su tecnología patentada NULISA™ y al sistema ARGO™ HT, la plataforma de Alamar está diseñada para ofrecer una sensibilidad ultraalta y abordar las principales limitaciones de las tecnologías existentes para
More news about: Alamar Biosciences, Inc.
Jan 12, 2026, 06:50 ET Alamar Biosciences ogłasza zamknięcie rundy finansowania oraz rozszerzenie zespołu kierowniczego
tworzeniem rozwiązań na potrzeby proteomiki ukierunkowanej w celu jak najwcześniejszego wykrywania chorób. Jej autorska platforma NULISA™ oraz system ARGO™ HT zapewniają ultrawysoką czułość detekcyjną, niwelując fundamentalne ograniczenia istniejących technologii w dziedzinie proteomiki ukierunkowanej. Więcej
More news about: Alamar Biosciences, Inc.
Jan 12, 2026, 05:29 ET 알라마 바이오사이언스, 목표액 초과 전환사채 자금 조달 완료…경영진 확대
기대한다"라고 덧붙였다.알라마 바이오사이언스 소개 알라마 바이오사이언스는 질병의 조기 진단을 앞당기는 정밀 단백질체학 기술을 개발하는 데 전념하는 비상장 생명과학 회사다. 알라마의 플랫폼은 자체 개발한 NULISA™ 기술과 ARGO™ HT 시스템을 활용해 초고감도 분석을 구현하도록 설계됐으며, 기존 기술의 주요 한계를 극복해 정밀 단백질체 분석을 지원한다. 자세한 내용은
More news about: Alamar Biosciences, Inc.
Jan 12, 2026, 03:31 ET Společnost Alamar Biosciences oznamuje, že poptávka investorů po konvertibilních dluhopisech převýšila nabídku a rozšíření vedoucího týmu
se věnuje vývoji přesné proteomiky umožňující včasnou detekci nemocí. Platforma společnosti Alamar využívá vlastní technologii NULISA™ a systém ARGO™ HT a je navržena tak, aby poskytovala mimořádně vysokou citlivost a řešila klíčová omezení stávajících technologií s cílem zajistit přesnou proteomiku.
More news about: Alamar Biosciences, Inc.
Jan 11, 2026, 19:02 ET Alamar Biosciences gibt Abschluss der überzeichneten Wandelanleihe-Finanzierung und Erweiterung des Führungsteams bekannt
hat, um die früheste Erkennung von Krankheiten zu ermöglichen. Die Plattform von Alamar nutzt die firmeneigene NULISA™-Technologie und das ARGO™ HT-System, um eine extrem hohe Empfindlichkeit zu erreichen und die wichtigsten Einschränkungen bestehender Technologien zu überwinden, um Präzisionsproteomik
More news about: Alamar Biosciences, Inc.
Jan 11, 2026, 18:56 ET Alamar Biosciences annonce la clôture d'un financement par billets convertibles sursouscrits et l'élargissement de l'équipe de direction
la protéomique de précision pour permettre la détection précoce des maladies. S'appuyant sur sa technologie propriétaire NULISA™ et le système ARGO™ HT, la plateforme d'Alamar est conçue pour offrir une sensibilité ultra-élevée et s'attaquer aux principales limites des technologies existantes pour offrir
More news about: Alamar Biosciences, Inc.
Jan 11, 2026, 16:15 ET Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team
company dedicated to powering precision proteomics to enable the earliest detection of disease. Leveraging its proprietary NULISA™ technology and the ARGO™ HT System, Alamar's platform is designed to deliver ultra-high sensitivity and addresses key limitations of existing technologies to deliver precision proteomics.
More news about: Alamar Biosciences, Inc.
Jan 11, 2026, 16:15 ET Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team
company dedicated to powering precision proteomics to enable the earliest detection of disease. Leveraging its proprietary NULISA™ technology and the ARGO™ HT System, Alamar's platform is designed to deliver ultra-high sensitivity and addresses key limitations of existing technologies to deliver precision proteomics.
More news about: Alamar Biosciences, Inc.
Jan 06, 2026, 12:30 ET ASUS Unveils Full-Spectrum AI and Always Incredible Innovations at CES 2026
ASUS ProArt PZ14 (HT7407) is the most powerful ASUS creator tablet, built for creating on the go. Powered by the 18-core Snapdragon® X2 Elite processor with up to
More news about: ASUS Computer International
Jan 05, 2026, 07:00 ET RedHill's RHB-102 Progresses in Multiple GI Indications Including GLP-1 Therapy-Related GI Side Effects
RHB-1021 is a proprietary, advanced clinical-stage, once-daily, bimodal extended-release, oral tablet formulation of 5-HT3 antagonist, ondansetron, targeting oncology support, acute gastroenteritis and gastritis, IBS-D and GLP-1/GIP-associated gastrointestinal
More news about: RedHill Biopharma Ltd.
Jan 02, 2026, 08:13 ET Hoth Therapeutics Expands Oncology Pipeline with Dual Patent Filings Establishing Novel Oncology Dermatology IP Platform
therapies, including second and third menin inhibitors.Together, these dual filings secure priority intellectual property rights around the use of HT-001 to treat dermatologic toxicities across multiple oncology treatment modalities, including radiation therapy and next-generation targeted agents.
More news about: Hoth Therapeutics, Inc.
Dec 22, 2025, 06:05 ET Jay Walker Names The Jay Walker Show as the Flagship Anchor of REVIVE as Network Goes Live in Homes
https://open.spotify.com/show/2tOoUbGBbyyyKM6wgqb2htWhere to watch:REVIVE — Daily, 8:00–9:00 p.m. ET / 7:00–8:00 p.m. CT
More news about: REVIVE MEDIA CO
Dec 19, 2025, 10:48 ET GAC Days | ¡El evento de prueba de conducción en Uruguay concluyó con éxito y se mostró una línea de productos diversificada para liderar la transición a la movilidad electrificada en América del Sur!
HYPTEC HT, que satisfacen plenamente las diversas necesidades de movilidad de los consumidores uruguayos.El número de consultas in situ y reservaciones de pruebas de manejo continuó aumentando durante el evento. Entre ellos, los tres modelos eléctricos puros AION UT, AION ES e HYPTEC HT se convirtieron
More news about: GAC
Dec 19, 2025, 01:53 ET 전국운동회의 중추: 'GAC의 힘'으로 홍콩과 마카오의 성공 견인
홍콩과 마카오 구간의 우측 핸들 요건에 맞춰 GAC는 지능형 신에너지 MPV E9 PHEV 185대와 럭셔리 지능형 전기 SUV 하이프텍 HT(HYPTEC HT) 180대 등 총 365대의 대회 전용 차량을 포함한 글로벌 맞춤형 모델을 특별 지원했다. 또한 GAC는 장애인 및 스페셜 올림픽 참가자들을 위한 특별 지원으로 E9 PHEV 휠체어 탑승 가능 차량(E9 PHEV Wheelchair-Accessible Vehicle)을
More news about: GAC
Dec 19, 2025, 01:50 ET 全国大会（National Games）のバックボーン：「GACの強み」で香港・マカオの成功を牽引
香港およびマカオ開催分の右ハンドル仕様に対応するため、GACは特別にグローバル・カスタマイズ・モデルを提供しました。その内訳は、知能型新エネルギーMPV「E9 PHEV」185台と高級知能型電気SUV「HYPTEC HT」180台を含む、計365台の大会専用車両です。さらに、パラリンピックおよびスペシャル・オリンピックスの参加者に特別なサポートを提供するため、GACは車椅子対応車両「E9 PHEV」を導入しました。「世界初の着脱式高級電動バリアフリー・シート」を装備し、バリアフリー移動のニーズを完全に満たしています。大会期間中、香港およびマカオ大会の組織委員会およびサービス・サポート・チームは、GACが提供した車両を高く評価しました。全国運動会香港地区事務処長のYEUNG
More news about: GAC
Dec 18, 2025, 12:06 ET La columna vertebral de los Juegos Nacionales:Impulsando el éxito en Hong Kong y Macao con la "Fuerza de GAC"
nivel mundial, incluyendo 185 unidades del monovolumen inteligente de nueva energía E9 PHEV y 180 unidades del SUV eléctrico inteligente de lujo HYPTEC HT, totalizando 365 vehículos específicos para el evento. Además, para brindar apoyo especial a los participantes de los Juegos Paralímpicos y Especiales,
More news about: GAC
Dec 18, 2025, 12:03 ET Das Rückgrat der Nationalen Spiele: Mit "GAC Strength" zum Erfolg in Hongkong und Macao
Modelle zur Verfügung - darunter 185 Einheiten des intelligenten New Energy MPV E9 PHEV und 180 Einheiten des luxuriösen intelligenten Elektro-SUV HYPTEC HT, insgesamt 365 veranstaltungsspezifische Fahrzeuge. Darüber hinaus hat GAC zur besonderen Unterstützung der Teilnehmer der Para & Special Games das
More news about: GAC